Related Experiment Video
Updated: Jun 5, 2026
07:15
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies
Published on: July 28, 2020
[Update from the soft tissue tumour registry in Jena]
I Petersen1, B Günther, K Mildner
1Institut für Pathologie, Universitätsklinikum Jena, Ziegelmühlenweg 1, 07740 Jena, Deutschland. iver.petersen@med.uni-jena.de
Der Pathologe
|December 21, 2010
Summary
This study analyzed 7043 soft tissue tumor cases from 2006-2007, finding malignant neoplasms were most common. Molecular pathology advancements are crucial for diagnosing these tumors, particularly sarcomas.
Area of Science:
- Pathology
- Oncology
- Molecular Biology
Context:
- The Jena Institute of Pathology, a German reference center since 1978, analyzed 7043 soft tissue tumor cases from 2006-2007.
- Soft tissue tumors represent a diverse group of neoplasms with varying biological potential.
Purpose:
- To provide an overview of clinicopathological data for soft tissue tumors.
- To update on diagnostic and research advancements in soft tissue tumor pathology.
- To highlight the role of molecular pathological analysis in diagnosis and research.
Summary:
- Analysis of 7043 cases revealed soft tissue tumors constituted over 77.7%, with 49% malignant, 11.4% intermediate, 35% benign, and 4.6% uncertain potential.
- Fibroblastic differentiation was the most frequent neoplastic type, with sarcomas occurring in patients averaging 63 years of age.
- Molecular diagnostics, including DNA probes for in situ hybridization and DNA chips for fusion transcripts, are advancing sarcoma diagnosis and research.
Impact:
- Establishes a clinicopathological baseline for soft tissue tumors in Germany.
- Emphasizes the growing importance of molecular pathology in accurate soft tissue tumor diagnosis.
- Contributes to ongoing research in specific biomarkers and pathomechanisms of sarcoma entities.
More Related Videos
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...